Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Classement en actions #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Prix de l'action
$0.8
Dernière synchronisation: 2024-01-02
Capitalisation boursière
$80.24M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange W World Corp. (WWHC)
Ratio P/S pour W World Corp. (WWHC)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de W World Corp., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour W World Corp. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes